相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Deep brain stimulation for monogenic Parkinson's disease: a systematic review
Tomi Kuusimaki et al.
JOURNAL OF NEUROLOGY (2020)
Non-motor Symptoms in Parkinson's Disease Patients with Parkin Mutations: More Depression and Less Executive Dysfunction
Jie Song et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Parkinson's disease: From bench to bedside
A. Draoui et al.
REVUE NEUROLOGIQUE (2020)
LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis
Chi G. Weindel et al.
ELIFE (2020)
Mitochondrial and Nuclear DNA Oxidative Damage in Physiological and Pathological Aging
Marta Kowalska et al.
DNA AND CELL BIOLOGY (2020)
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2
Andrea Mancini et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
L-3,4-dihydroxyphenylalanine (L-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease
Jessica L. Billings et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Deep brain stimulation: current challenges and future directions
Andres M. Lozano et al.
NATURE REVIEWS NEUROLOGY (2019)
DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic Perspectives
Mariaelena Repici et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Thalamic and ventricular volumes predict motor response to deep brain stimulation for Parkinson's disease
John R. Younce et al.
PARKINSONISM & RELATED DISORDERS (2019)
Deep Brain Stimulation in Patients With Mutations in Parkinson's Disease-Related Genes: A Systematic Review
Lais Machado de Oliveira et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2019)
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease A Systematic Review and Meta-analysis
Carlo Alberto Artusi et al.
JAMA NETWORK OPEN (2019)
The Changing Landscape of Surgery for Parkinson's Disease
Christopher S. Lozano et al.
MOVEMENT DISORDERS (2018)
Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo
Owen Scudamore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Building and decoding ubiquitin chains for mitophagy
J. Wade Harper et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
Pavel V. Nekrasov et al.
NEURAL REGENERATION RESEARCH (2018)
Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia A Randomized Clinical Trial
James Gratwicke et al.
JAMA NEUROLOGY (2018)
A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes
Peter J. Teravskis et al.
JOURNAL OF NEUROSCIENCE (2018)
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes
S. L. Sison et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Recent Advances in Biomarkers for Parkinson's Disease
Runcheng He et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants
Manish Verma et al.
JOURNAL OF NEUROSCIENCE (2017)
Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson's disease
Harith Akram et al.
NEUROIMAGE (2017)
Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture
Thomas Misgeld et al.
NEURON (2017)
Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats
Yin Weilan et al.
NEUROSCIENCE LETTERS (2017)
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Fabio A. Zucca et al.
PROGRESS IN NEUROBIOLOGY (2017)
Oxidative stress and cellular pathologies in Parkinson's disease
Lesly Puspita et al.
MOLECULAR BRAIN (2017)
Control of mitochondrial biogenesis and function by the ubiquitin - proteasome system
Piotr Bragoszewski et al.
OPEN BIOLOGY (2017)
Effects of DBS in parkinsonian patients depend on the structural integrity of frontal cortex
Muthuraman Muthuraman et al.
SCIENTIFIC REPORTS (2017)
Parkin and PINK1 functions in oxidative stress and neurodegeneration
Sandeep K. Barodia et al.
BRAIN RESEARCH BULLETIN (2017)
Noninvasive Deep Brain Stimulation via Temporally Interfering Electric Fields
Nir Grossman et al.
CELL (2017)
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
Andrea Herrera et al.
ACS CHEMICAL NEUROSCIENCE (2017)
The genetic background of Parkinson's disease: current progress and future prospects
K. Kalinderi et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
Emma Deas et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson's Disease
Chung-Han Hsieh et al.
CELL STEM CELL (2016)
Alpha-synuclein structure, functions, and interactions
Fatemeh Nouri Emamzadeh
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2016)
LRRK2 Regulates Voltage-Gated Calcium Channel Function
Cade Bedford et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1
Celia van der Merwe et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2015)
The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture
Nicola J. Rutherford et al.
NEUROSCIENCE LETTERS (2015)
The Medical Treatment of Parkinson Disease from James Parkinson to George Cotzias
Stanley Fahn
MOVEMENT DISORDERS (2015)
Molecular Effects of L-dopa Therapy in Parkinson's Disease
Jolanta Dorszewska et al.
CURRENT GENOMICS (2014)
Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila
Dario C. Angeles et al.
HUMAN MOLECULAR GENETICS (2014)
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells
Mohamed-Bilal Fares et al.
HUMAN MOLECULAR GENETICS (2014)
Divergent effects of the H5OQ and G51D SNCA mutations on the aggregation of α-synuclein
Nicola J. Rutherford et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Protective and toxic roles of dopamine in Parkinson's disease
Juan Segura-Aguilar et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain
Giovanni Piccoli et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology
Petra Pasanen et al.
NEUROBIOLOGY OF AGING (2014)
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
David C. Schoendorf et al.
NATURE COMMUNICATIONS (2014)
Morphological and bioenergetic demands underlying the nnitophagy in post-mitotic neurons: the pink parkin pathway
Giuseppina Amadoro et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Aoife P. Kiely et al.
ACTA NEUROPATHOLOGICA (2013)
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
Michael H. Yan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Orly Weinreb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Phosphatase and Tensin Homolog (PTEN)-induced Putative Kinase 1 (PINK1)-dependent Ubiquitination of Endogenous Parkin Attenuates Mitophagy STUDY IN HUMAN PRIMARY FIBROBLASTS AND INDUCED PLURIPOTENT STEM CELL-DERIVED NEURONS
Aleksandar Rakovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Silke Appel-Cresswell et al.
MOVEMENT DISORDERS (2013)
L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells
Branden J. Stansley et al.
NEUROPHARMACOLOGY (2013)
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study
Guenther Deuschl et al.
PARKINSONISM & RELATED DISORDERS (2013)
The Role of Oxidative Stress in Parkinson's Disease
Vera Dias et al.
JOURNAL OF PARKINSONS DISEASE (2013)
Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease
Gulnur Andican et al.
ACTA NEUROLOGICA BELGICA (2012)
Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death
Su-Jeong Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1
Xinglong Wang et al.
HUMAN MOLECULAR GENETICS (2012)
Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 and Cys-53
Stefania Girotto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Role of Autophagy in Parkinson's Disease
Melinda A. Lynch-Day et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Dopamine Oxidation and Autophagy
Patricia Munoz et al.
PARKINSONS DISEASE (2012)
Deep Brain Stimulation for Parkinson Disease An Expert Consensus and Review of Key Issues
Jeff M. Bronstein et al.
ARCHIVES OF NEUROLOGY (2011)
Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization
Victor S. Van Laar et al.
HUMAN MOLECULAR GENETICS (2011)
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy
Kelly Jean Thomas et al.
HUMAN MOLECULAR GENETICS (2011)
Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of L-DOPA treatment
Karen L. Eskow Jaunarajs et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Genetic mutations and functions of PINK1
Sumihiro Kawajiri et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Deep Brain Stimulation Results in Local Glutamate and Adenosine Release: Investigation Into the Role of Astrocytes
Vivianne L. Tawfik et al.
NEUROSURGERY (2010)
Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications
Rebecca Banerjee et al.
TRENDS IN NEUROSCIENCES (2010)
DJ-1 binds to mitochondrial complex I and maintains its activity
Takuya Hayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders
Philipp J. Kahle et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease A Randomized Controlled Trial
Frances M. Weaver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission
Ruben K. Dagda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mitochondrial Localization of DJ-1 Leads to Enhanced Neuroprotection
Eunsung Junn et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death
Sonia Gandhi et al.
MOLECULAR CELL (2009)
Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells
Victor S. Van Laar et al.
NEUROBIOLOGY OF DISEASE (2009)
L-DOPA Neurotoxicity Is Mediated by Up-Regulation of DMT1-IRE Expression
Fang Du et al.
PLOS ONE (2009)
Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration
Suzana Gispert et al.
PLOS ONE (2009)
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease
Selma Aybek et al.
PARKINSONISM & RELATED DISORDERS (2009)
The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex
Stefan Droese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Derek Narendra et al.
JOURNAL OF CELL BIOLOGY (2008)
Repair system of 7,8-dihydro-8-oxoguanine as a defense line against carcinogenesis
Takeshi Hirano
JOURNAL OF RADIATION RESEARCH (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Review:: Familial Parkinson's disease -: genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease
Carola Schiesling et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Clement A. Gautier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1
Julia W. Pridgeon et al.
PLOS BIOLOGY (2007)
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
J. Fuchs et al.
NEUROLOGY (2007)
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
L. N. Clark et al.
NEUROLOGY (2006)
Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease
Masaaki Waragai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease
Beisha Tang et al.
HUMAN MOLECULAR GENETICS (2006)
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
A Bender et al.
NATURE GENETICS (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T α-synuclein toxicity
WB Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
G2019S LRRK2 mutation in French and North African families with Parkinson's disease
S Lesage et al.
ANNALS OF NEUROLOGY (2005)
Parkinson disease, brain volumes, and subthalamic nucleus stimulation
F Bonneville et al.
NEUROLOGY (2005)
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
RH Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Peculiarities of L-DOPA treatment of Parkinson's disease
RM Kostrzewa et al.
AMINO ACIDS (2005)
Hydrogen sulfide protects neurons from oxidative stress
Y Kimura et al.
FASEB JOURNAL (2004)
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice
JJ Palacino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies
BR Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells
M Shamoto-Nagai et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Effect of wild-type or mutant parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome
DH Hyun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s
DI Pattison et al.
TOXICOLOGY (2002)
Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties)
M Gesi et al.
PHARMACOLOGY & TOXICOLOGY (2001)
Ubiquitination of a new form of α-synuclein by parkin from human brain:: Implications for Parkinson's disease
H Shimura et al.
SCIENCE (2001)
Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain
FH Khan et al.
BRAIN RESEARCH (2001)
Sensitization of neuronal cells to oxidative stress with mutated human α-synuclein
LW Ko et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Association between early-onset Parkinson's disease and mutations in the parkin gene
CB Lücking et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)